Literature DB >> 8182949

Lymphoid blast crisis of B-lineage phenotype with monosomy 7 in a patient with juvenile chronic myelogenous leukemia (JCML).

R C Lau1, J Squire, L Brisson, S Kamel-Reid, T Grunberger, I Dubé, M Letarte, K Shannon, M H Freedman.   

Abstract

We studied a patient with juvenile chronic myelogenous leukemia (JCML) whose terminal course was characterized by transformation to acute lymphoblastic leukemia. Karyotypic studies identified monosomy 7 in leukemic myelomonocytic marrow cells during the chronic phase and in the lymphoblasts during the transformation phase. Our ability to sustain the transformed lymphoblasts in culture allowed us to characterize them further. CD19, HLA-DR, and CD10 were present, consistent with a pre-B acute lymphoblastic leukemia phenotype. CD14 (My-4) and CD13 (My-7) were negative. Rearrangement of immunoglobulin heavy- and light-chain genes identified monoclonal populations of cells of the B lineage. This case provides further evidence that JCML is a clonal disease of pluripotent stem-cell origin.

Entities:  

Mesh:

Year:  1994        PMID: 8182949

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  6 in total

1.  Lethal proliferation of erythroid precursors in a neonate with a germline PTPN11 mutation.

Authors:  Christian Peter Kratz; Michaela Nathrath; Peter Freisinger; Petra Dressel; Hans-Peter Assmuss; Cornelia Klein; Ayami Yoshimi; Stefan Burdach; Charlotte Marie Niemeyer
Journal:  Eur J Pediatr       Date:  2005-12-21       Impact factor: 3.183

2.  Establishment of a monosomy 7 leukemia cell line, MONO-7, with a ras gene mutation.

Authors:  Hiroyuki Fujisaki; Kenji Takai; Sawada Akihisa; Sadao Tokimasa; Yoshiko Matsuda; Hideaki Ohta; Yuko Osugi; Ji Yoo Kim; Gaku Hosoi; Masahiro Sako; Junichi Hara
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

3.  Quantitative effects of Nf1 inactivation on in vivo hematopoiesis.

Authors:  Y Zhang; B R Taylor; K Shannon; D W Clapp
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

4.  Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemia.

Authors:  Saman K Hashmi; Jyotinder N Punia; Andrea N Marcogliese; Amos S Gaikwad; Kevin E Fisher; Angshumoy Roy; Pulivarthi Rao; Dolores H Lopez-Terrada; Jo Ringrose; Mignon L Loh; Charlotte M Niemeyer; Rachel E Rau
Journal:  Pediatr Blood Cancer       Date:  2019-06-28       Impact factor: 3.167

5.  Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartment.

Authors:  Aurélie Caye; Kevin Rouault-Pierre; Marion Strullu; Elodie Lainey; Ander Abarrategi; Odile Fenneteau; Chloé Arfeuille; Jennifer Osman; Bruno Cassinat; Sabrina Pereira; Fernando Anjos-Afonso; Erin Currie; Linda Ariza-McNaughton; Vincent Barlogis; Jean-Hugues Dalle; André Baruchel; Christine Chomienne; Hélène Cavé; Dominique Bonnet
Journal:  Leukemia       Date:  2019-11-27       Impact factor: 11.528

Review 6.  Genomic and Epigenomic Landscape of Juvenile Myelomonocytic Leukemia.

Authors:  Claudia Fiñana; Noel Gómez-Molina; Sandra Alonso-Moreno; Laura Belver
Journal:  Cancers (Basel)       Date:  2022-03-04       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.